Lung adenocarcinoma patients with KEAP1 mutation harboring low immune cell infiltration and low activity of immune environment
Abstract Background Kelch‐like ECH‐associated protein 1 (KEAP1) has been identified as a cancer driver gene in lung adenocarcinoma (LUAD), and increased evidence has given us clues about the association of KEAP1 mutation and immune characteristics. We assessed the association between KEAP1 mutation...
Main Authors: | Wanwan Cheng, Bin Xu, Haitao Zhang, Shencun Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-09-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14089 |
Similar Items
-
Keap1 Expression for Predicting the Chemoresistance and Prognosis of Advanced
Non-small Cell Lung Cancer
by: Baoshan CAO, et al.
Published: (2012-10-01) -
Synthesis of Novel Nitrogen-Containing Heterocycle Bromophenols and Their Interaction with Keap1 Protein by Molecular Docking
by: Xiu E. Feng, et al.
Published: (2017-12-01) -
Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas
by: Xing Jin, et al.
Published: (2021-12-01) -
BAP1 Downregulates NRF2 Target Genes and Exerts Anti-Tumorigenic Effects by Deubiquitinating KEAP1 in Lung Adenocarcinoma
by: Jong-Su Kang, et al.
Published: (2022-01-01) -
Epigenetic Scanning of <i>KEAP1</i> CpG Sites Uncovers New Molecular-Driven Patterns in Lung Adeno and Squamous Cell Carcinomas
by: Federico Pio Fabrizio, et al.
Published: (2020-09-01)